These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

188 related items for PubMed ID: 9106913

  • 1. In vivo effects on striatal dopamine D2 receptor binding by the novel atypical antipsychotic drug sertindole--a 123I IBZM single photon emission tomography (SPET) study.
    Pilowsky LS, O'Connell P, Davies N, Busatto GF, Costa DC, Murray RM, Ell PJ, Kerwin RW.
    Psychopharmacology (Berl); 1997 Mar; 130(2):152-8. PubMed ID: 9106913
    [Abstract] [Full Text] [Related]

  • 2. Striatal and temporal cortical D2/D3 receptor occupancy by olanzapine and sertindole in vivo: a [123I]epidepride single photon emission tomography (SPET) study.
    Bigliani V, Mulligan RS, Acton PD, Ohlsen RI, Pike VW, Ell PJ, Gacinovic S, Kerwin RW, Pilowsky LS.
    Psychopharmacology (Berl); 2000 Jun; 150(2):132-40. PubMed ID: 10907666
    [Abstract] [Full Text] [Related]

  • 3. Dopamine D2 receptor blockade in vivo with the novel antipsychotics risperidone and remoxipride--an 123I-IBZM single photon emission tomography (SPET) study.
    Busatto GF, Pilowsky LS, Costa DC, Ell PJ, Verhoeff NP, Kerwin RW.
    Psychopharmacology (Berl); 1995 Jan; 117(1):55-61. PubMed ID: 7536945
    [Abstract] [Full Text] [Related]

  • 4. Dopamine D2 receptor occupancy in vivo by the novel atypical antipsychotic olanzapine--a 123I IBZM single photon emission tomography (SPET) study.
    Pilowsky LS, Busatto GF, Taylor M, Costa DC, Sharma T, Sigmundsson T, Ell PJ, Nohria V, Kerwin RW.
    Psychopharmacology (Berl); 1996 Mar; 124(1-2):148-53. PubMed ID: 8935810
    [Abstract] [Full Text] [Related]

  • 5. Sertindole and dopamine D2 receptor occupancy in comparison to risperidone, clozapine and haloperidol - a 123I-IBZM SPECT study.
    Kasper S, Tauscher J, Küfferle B, Barnas C, Hesselmann B, Asenbaum S, Podreka I, Brücke T.
    Psychopharmacology (Berl); 1998 Apr; 136(4):367-73. PubMed ID: 9600582
    [Abstract] [Full Text] [Related]

  • 6. Striatal dopamine-2 receptor occupancy as measured with [123I]iodobenzamide and SPECT predicted the occurrence of EPS in patients treated with atypical antipsychotics and haloperidol.
    Tauscher J, Küfferle B, Asenbaum S, Tauscher-Wisniewski S, Kasper S.
    Psychopharmacology (Berl); 2002 Jun; 162(1):42-9. PubMed ID: 12107616
    [Abstract] [Full Text] [Related]

  • 7. In vivo effects of olanzapine on striatal dopamine D(2)/D(3) receptor binding in schizophrenic patients: an iodine-123 iodobenzamide single-photon emission tomography study.
    Dresel S, Mager T, Rossmüller B, Meisenzahl E, Hahn K, Möller HJ, Tatsch K.
    Eur J Nucl Med; 1999 Aug; 26(8):862-8. PubMed ID: 10436199
    [Abstract] [Full Text] [Related]

  • 8. D2 occupancy, extrapyramidal side effects and antipsychotic drug treatment: a pilot study with sertindole in healthy subjects.
    Farde L, Mack RJ, Nyberg S, Halldin C.
    Int Clin Psychopharmacol; 1997 Feb; 12 Suppl 1():S3-7. PubMed ID: 9179638
    [Abstract] [Full Text] [Related]

  • 9. Evaluation of Antipsychotic Dose Reduction in Late-Life Schizophrenia: A Prospective Dopamine D2/3 Receptor Occupancy Study.
    Graff-Guerrero A, Rajji TK, Mulsant BH, Nakajima S, Caravaggio F, Suzuki T, Uchida H, Gerretsen P, Mar W, Pollock BG, Mamo DC.
    JAMA Psychiatry; 2015 Sep; 72(9):927-34. PubMed ID: 26131622
    [Abstract] [Full Text] [Related]

  • 10. In vivo 123I IBZM SPECT imaging of striatal dopamine-2 receptor occupancy in schizophrenic patients treated with olanzapine in comparison to clozapine and haloperidol.
    Tauscher J, Küfferle B, Asenbaum S, Fischer P, Pezawas L, Barnas C, Tauscher-Wisniewski S, Brücke T, Kasper S.
    Psychopharmacology (Berl); 1999 Jan; 141(2):175-81. PubMed ID: 9952042
    [Abstract] [Full Text] [Related]

  • 11. Iodine-123-iodobenzamide SPECT assessment of dopamine D2 receptor occupancy in riperidone-treated schizophrenic patients.
    Dresel S, Tatsch K, Dähne I, Mager T, Scherer J, Hahn K.
    J Nucl Med; 1998 Jul; 39(7):1138-42. PubMed ID: 9669383
    [Abstract] [Full Text] [Related]

  • 12. Striatal dopaminergic D2 receptor occupancy and clinical efficacy in psychosis exacerbation: a 123I-IBZM study with ziprasidone and haloperidol.
    Corripio I, Catafau AM, Perez V, Puigdemont D, Mena E, Aguilar Y, Carrió I, Alvarez E.
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jan; 29(1):91-6. PubMed ID: 15610950
    [Abstract] [Full Text] [Related]

  • 13. D2-dopamine receptor occupancy measured by IBZM-SPECT in relation to extrapyramidal side effects.
    Broich K, Grünwald F, Kasper S, Klemm E, Biersack HJ, Möller HJ.
    Pharmacopsychiatry; 1998 Sep; 31(5):159-62. PubMed ID: 9832346
    [Abstract] [Full Text] [Related]

  • 14. IBZM SPECT imaging of striatal dopamine-2 receptors in psychotic patients treated with the novel antipsychotic substance quetiapine in comparison to clozapine and haloperidol.
    Küfferle B, Tauscher J, Asenbaum S, Vesely C, Podreka I, Brücke T, Kasper S.
    Psychopharmacology (Berl); 1997 Oct; 133(4):323-8. PubMed ID: 9372530
    [Abstract] [Full Text] [Related]

  • 15. Occupancy of dopamine D2 receptors by the atypical antipsychotic drugs risperidone and olanzapine: theoretical implications.
    Frankle WG, Gil R, Hackett E, Mawlawi O, Zea-Ponce Y, Zhu Z, Kochan LD, Cangiano C, Slifstein M, Gorman JM, Laruelle M, Abi-Dargham A.
    Psychopharmacology (Berl); 2004 Oct; 175(4):473-80. PubMed ID: 15083259
    [Abstract] [Full Text] [Related]

  • 16. Optimizing limbic selective D2/D3 receptor occupancy by risperidone: a [123I]-epidepride SPET study.
    Bressan RA, Erlandsson K, Jones HM, Mulligan RS, Ell PJ, Pilowsky LS.
    J Clin Psychopharmacol; 2003 Feb; 23(1):5-14. PubMed ID: 12544369
    [Abstract] [Full Text] [Related]

  • 17. Double-blind olanzapine vs. haloperidol D2 dopamine receptor blockade in schizophrenic patients: a baseline-endpoint.
    Bernardo M, Parellada E, Lomeña F, Catafau AM, Font M, Gómez JC, López-Carrero C, Gutiérrez F, Pavía J, Salamero M.
    Psychiatry Res; 2001 Aug 25; 107(2):87-97. PubMed ID: 11530275
    [Abstract] [Full Text] [Related]

  • 18. Antipsychotic medication, D2 dopamine receptor blockade and clinical response: a 123I IBZM SPET (single photon emission tomography) study.
    Pilowsky LS, Costa DC, Ell PJ, Murray RM, Verhoeff NP, Kerwin RW.
    Psychol Med; 1993 Aug 25; 23(3):791-7. PubMed ID: 7901865
    [Abstract] [Full Text] [Related]

  • 19. The role of striatal dopamine D2 receptors in the occurrence of extrapyramidal side effects: iodine-123-iodobenzamide single photon emission computed tomography study.
    Corripio I, Ferreira A, Portella MJ, Pérez V, Escartí MJ, Del Valle Camacho M, Sauras RB, Alonso A, Grasa EM, Carrió I, Catafau AM, Alvarez E.
    Psychiatry Res; 2012 Jan 30; 201(1):73-7. PubMed ID: 22281201
    [Abstract] [Full Text] [Related]

  • 20. Low striatal and extra-striatal D2 receptor occupancy during treatment with the atypical antipsychotic sertindole.
    Nyberg S, Olsson H, Nilsson U, Maehlum E, Halldin C, Farde L.
    Psychopharmacology (Berl); 2002 Jun 30; 162(1):37-41. PubMed ID: 12107615
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.